Literature DB >> 6434116

Mechanism of polyuria and natriuresis in atrioventricular nodal tachycardia.

R Canepa-Anson, M Williams, J Marshall, T Mitsuoka, S Lightman, R Sutton.   

Abstract

A woman with tachycardia associated with polyuria was investigated. Electrophysiological analysis showed that the tachycardia was an atrioventricular nodal re-entrant tachycardia. Programmed stimulation was then used to provoke and sustain the tachycardia for 40 minutes. Polyuria, with an appreciable increase in free water clearance, was observed. This was associated with reduction in plasma and urinary arginine vasopressin concentrations. Appreciable natriuresis also developed. These results support the hypothesis that the polyuria with increased free water clearance and the natriuresis occurring during sustained tachycardia in man are due to inhibition of secretion of vasopressin and the release of natriuretic factor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434116      PMCID: PMC1443391          DOI: 10.1136/bmj.289.6449.866

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Polyuria in paroxysmal tachycardia and paroxysmal atrial flutter and fibrillation.

Authors:  P WOOD
Journal:  Br Heart J       Date:  1963-05

2.  Evidence of the atrial location of receptors influencing urine flow.

Authors:  J P HENRY; O H GAUER; J L REEVES
Journal:  Circ Res       Date:  1956-01       Impact factor: 17.367

3.  Mechanism of diuretic response associated with atrial tachycardia.

Authors:  J Boykin; P Cadnapaphornchai; K M McDonald; R W Schrier
Journal:  Am J Physiol       Date:  1975-12

4.  Suppression of ADH during water immersion in normal man.

Authors:  M Epstein; D S Pins; M Miller
Journal:  J Appl Physiol       Date:  1975-06       Impact factor: 3.531

Review 5.  The regulation of extracellular fluid volume.

Authors:  O H Gauer; J P Henry; C Behn
Journal:  Annu Rev Physiol       Date:  1970       Impact factor: 19.318

6.  Selected clinical features of paroxysmal tachycardia. A prospective study in 120 patients.

Authors:  M H Luria
Journal:  Br Heart J       Date:  1971-05

Review 7.  Role of cardiovascular receptors in the control of ADH release.

Authors:  L Share
Journal:  Cardiology       Date:  1976       Impact factor: 1.869

8.  Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP).

Authors:  K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

9.  Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria.

Authors:  M G Currie; D M Geller; B R Cole; J G Boylan; W YuSheng; S W Holmberg; P Needleman
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

10.  Effects of left atrial stretch in cardiac-denervated and intact conscious dogs.

Authors:  D C Fater; H D Schultz; W D Sundet; J S Mapes; K L Goetz
Journal:  Am J Physiol       Date:  1982-06
View more
  4 in total

1.  Plasma atrial natriuretic polypeptide concentrations during and after reversion of paroxysmal supraventricular tachycardias.

Authors:  J R Oliver; N Twidale; C Lakin; M Cain; A M Tonkin
Journal:  Br Heart J       Date:  1988-04

2.  Signals from the oropharynx may contribute to the diuresis which occurs in man to drinking isotonic fluids.

Authors:  E M Gebruers; W J Hall; M H O'Brien; D O'Leary; W D Plant
Journal:  J Physiol       Date:  1985-06       Impact factor: 5.182

3.  Effects of the administration of thyroid hormone on the plasma levels of atrial natriuretic peptides and on atrial myoendocrine cells in the rat: an immunochemical, ultrastructural, and stereological study.

Authors:  G Cavallini; A Clerico; M Del Chicca; V De Tata; Z Gori; E Bergamini
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

4.  Plasma alpha natriuretic peptide in cardiac impairment.

Authors:  A M Richards; J G Cleland; G Tonolo; G D McIntyre; B J Leckie; H J Dargie; S G Ball; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.